Related to Neurodegenerative diseases
Suven Life Sciences announced today that the grant of two product patents from USA (8598204 & 8551718) corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2029 and 2030 respectively.With these new patents, Suven has a total of 17 granted patents from USA.
Powered by Capital Market - Live News
